
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 52
Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
Astrocytes in human central nervous system diseases: a frontier for new therapies
Alexei Verkhratsky, Arthur M. Butt, Baoman Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
Alexei Verkhratsky, Arthur M. Butt, Baoman Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 59
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 59
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 81-106
Open Access | Times Cited: 39
Ludovica Iovino, Veronica Giusti, Francesca Pischedda, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 1, pp. 81-106
Open Access | Times Cited: 39
Astrocytic modulation of neuronal signalling
Sushmitha S. Purushotham, Yossi Buskila
Frontiers in Network Physiology (2023) Vol. 3
Open Access | Times Cited: 30
Sushmitha S. Purushotham, Yossi Buskila
Frontiers in Network Physiology (2023) Vol. 3
Open Access | Times Cited: 30
Astroglia support, regulate and reinforce brain barriers
Alexei Verkhratsky, Augustas Pivoriūnas
Neurobiology of Disease (2023) Vol. 179, pp. 106054-106054
Open Access | Times Cited: 29
Alexei Verkhratsky, Augustas Pivoriūnas
Neurobiology of Disease (2023) Vol. 179, pp. 106054-106054
Open Access | Times Cited: 29
Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
Furkan Eker, Ecem Bolat, Burcu Pekdemir, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Furkan Eker, Ecem Bolat, Burcu Pekdemir, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
ER-mitochondria distance is a critical parameter for efficient mitochondrial Ca2+ uptake and oxidative metabolism
Giulia Dematteis, Laura Tapella, Claudio Casali, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Giulia Dematteis, Laura Tapella, Claudio Casali, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease
Meritxell Pons‐Espinal, Lucas Blasco-Agell, Irene Fernández‐Carasa, et al.
JCI Insight (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 11
Meritxell Pons‐Espinal, Lucas Blasco-Agell, Irene Fernández‐Carasa, et al.
JCI Insight (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 11
Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive
Nerea Urrestizala-Arenaza, Sonia Cerchio, Fabio Cavaliere, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 10
Nerea Urrestizala-Arenaza, Sonia Cerchio, Fabio Cavaliere, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 10
Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 33
Anindita Bose, Gregory A. Petsko, Lorenz Studer
Trends in Neurosciences (2022) Vol. 45, Iss. 8, pp. 608-620
Open Access | Times Cited: 33
A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
Sheng Li, Yanbing Liu, Sen Lu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 7
Sheng Li, Yanbing Liu, Sen Lu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 7
Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease
Kendra L. Hanslik, Kaitlyn M. Marino, Tyler K. Ulland
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 40
Kendra L. Hanslik, Kaitlyn M. Marino, Tyler K. Ulland
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 40
Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models
David Labib, Zhen Wang, Priya Prakash, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
David Labib, Zhen Wang, Priya Prakash, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Astrocytes in Neurodegeneration: Inspiration From Genetics
Jingxuan Huang, Chunyu Li, Huifang Shang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Jingxuan Huang, Chunyu Li, Huifang Shang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 24
Therapeutic Potential of Astrocyte Transplantation
Nataly Hastings, Wei‐Li Kuan, Andrew Osborne, et al.
Cell Transplantation (2022) Vol. 31
Open Access | Times Cited: 24
Nataly Hastings, Wei‐Li Kuan, Andrew Osborne, et al.
Cell Transplantation (2022) Vol. 31
Open Access | Times Cited: 24
Expression of G2019S LRRK2 in Rat Primary Astrocytes Mediates Neurotoxicity and Alters the Dopamine Synthesis Pathway in N27 Cells via Astrocytic Proinflammatory Cytokines and Neurotrophic Factors
Dong Hwan Ho, Hye Jung Kim, Daleum Nam, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4324-4336
Open Access | Times Cited: 5
Dong Hwan Ho, Hye Jung Kim, Daleum Nam, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4324-4336
Open Access | Times Cited: 5
Calcium Deregulation in Neurodegeneration and Neuroinflammation in Parkinson’s Disease: Role of Calcium-Storing Organelles and Sodium–Calcium Exchanger
Guendalina Bastioli, Silvia Piccirillo, Laura Graciotti, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1301-1301
Open Access | Times Cited: 4
Guendalina Bastioli, Silvia Piccirillo, Laura Graciotti, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1301-1301
Open Access | Times Cited: 4
Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders
Chiara F. Valori, Agostino Possenti, Liliana Brambilla, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2019-2019
Open Access | Times Cited: 27
Chiara F. Valori, Agostino Possenti, Liliana Brambilla, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2019-2019
Open Access | Times Cited: 27
Antioxidative role of Traditional Chinese Medicine in Parkinson's disease
Fahim Muhammad, Yan Liu, Yongtao Zhou, et al.
Journal of Ethnopharmacology (2021) Vol. 285, pp. 114821-114821
Closed Access | Times Cited: 27
Fahim Muhammad, Yan Liu, Yongtao Zhou, et al.
Journal of Ethnopharmacology (2021) Vol. 285, pp. 114821-114821
Closed Access | Times Cited: 27
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Biomolecules (2023) Vol. 13, Iss. 1, pp. 178-178
Open Access | Times Cited: 10
Tatou Iseki, Yuzuru Imai, Nobutaka Hattori
Biomolecules (2023) Vol. 13, Iss. 1, pp. 178-178
Open Access | Times Cited: 10
Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons
Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access
Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, et al.
BMC Neuroscience (2025) Vol. 26, Iss. 1
Open Access
Immune cell metabolic dysfunction in Parkinson’s disease
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Julian R Mark, Malú G. Tansey
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Connexin 43 is downregulated in advanced Parkinson’s disease in multiple brain regions which correlates with symptoms
Nataly Hastings, S.M. Jamshedur Rahman, Przemysław Stempor, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nataly Hastings, S.M. Jamshedur Rahman, Przemysław Stempor, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
Dmitry Lim, Carlos Matute, Fabio Cavaliere, et al.
Handbook of clinical neurology (2025), pp. 9-44
Closed Access
Dmitry Lim, Carlos Matute, Fabio Cavaliere, et al.
Handbook of clinical neurology (2025), pp. 9-44
Closed Access
General pathophysiology of neuroglia
Alexei Verkhratsky, Elly M. Hol, Lot D. de Witte, et al.
Handbook of clinical neurology (2025), pp. 3-7
Closed Access
Alexei Verkhratsky, Elly M. Hol, Lot D. de Witte, et al.
Handbook of clinical neurology (2025), pp. 3-7
Closed Access